Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-20

FDA Approved: TAZAROTENE — Original Application (Solaris Pharma Corporation)

View source ↗

Summary

The FDA approved a generic version of tazarotene (topical retinoid) from Solaris Pharma Corporation through an Original Abbreviated New Drug Application (ANDA 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAZAROTENE (TAZAROTENE)

Snippet

ORIG AP for TAZAROTENE (TAZAROTENE)